{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:53:01Z","timestamp":1774533181957,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.tripleo.2011.01.017","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T22:00:01Z","timestamp":1301695201000},"page":"41-47","source":"Crossref","is-referenced-by-count":9,"title":["Hemimandibulectomy after bisphosphonate treatment for complex regional pain syndrome: A case report and review on the prevention and treatment of bisphosphonate-related osteonecrosis of the jaw"],"prefix":"10.1016","volume":"113","author":[{"given":"Thomas","family":"Bittner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natascha","family":"Lorbeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Reuther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander C.","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs D.A.","family":"M\u00fcller-Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2011.01.017_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.01.017_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/jnci\/djm029","article-title":"Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions","volume":"99","author":"Woo","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.tripleo.2011.01.017_bib3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","article-title":"Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome","volume":"18","author":"Yarom","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.tripleo.2011.01.017_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00774-010-0162-7","volume":"28","author":"Yoneda","year":"2010","journal-title":"J Bone Miner Metab"},{"issue":"5 Suppl","key":"10.1016\/j.tripleo.2011.01.017_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.joms.2008.12.006","article-title":"Alternative indications for bisphosphonate therapy","volume":"67","author":"Landesberg","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.01.017_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2009.09.023","article-title":"The fascination of complex regional pain syndrome","volume":"221","author":"J\u00e4nig","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.tripleo.2011.01.017_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1533-2500.2009.00262.x","article-title":"Current understandings on complex regional pain syndrome","volume":"9","author":"de Mos","year":"2009","journal-title":"Pain Pract"},{"key":"10.1016\/j.tripleo.2011.01.017_bib8","first-page":"278","article-title":"Complex regional pain syndrome (CRPS) type-1 following snake bite: a case report","volume":"10","author":"Bhattarai","year":"2008","journal-title":"Nepal Med Coll J"},{"key":"10.1016\/j.tripleo.2011.01.017_bib9","series-title":"Leitlinien f\u00fcr die Diagnostik und Therapie in der Neurologie","author":"Diener","year":"2008"},{"key":"10.1016\/j.tripleo.2011.01.017_bib10","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.tripleo.2011.01.017_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","article-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer","volume":"96","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"12 Suppl","key":"10.1016\/j.tripleo.2011.01.017_bib12","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.tripleo.2011.01.017_bib13","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","article-title":"Bisphosphonates: mechanisms of action","volume":"97","author":"Rodan","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tripleo.2011.01.017_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5694\/j.1326-5377.2005.tb06761.x","article-title":"Bisphosphonates and avascular necrosis of the jaw: a possible association","volume":"182","author":"Carter","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.tripleo.2011.01.017_bib15","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.tripleo.2008.03.005","article-title":"Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications","volume":"106","author":"Migliorati","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2011.01.017_bib16","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.tripleo.2011.01.017_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.tripleo.2011.01.017_bib18","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tripleo.2011.01.017_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00432-009-0662-9","article-title":"Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy","volume":"136","author":"Jung","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.tripleo.2011.01.017_bib20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.01.017_bib21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tripleo.2011.01.017_bib22","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tripleo.2011.01.017_bib23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies","volume":"44","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.tripleo.2011.01.017_bib24","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tripleo.2011.01.017_bib25","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.tripleo.2011.01.017_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.01.017_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"Position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.01.017_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JOP.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.tripleo.2011.01.017_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.01.017_bib30","first-page":"510","article-title":"Zahn\u00e4rztliche Betreuung von Patienten unter\/nach Bisphosphonat-Medikation","volume":"61","author":"Gr\u00f6tz","year":"2006","journal-title":"Dtsch Zahn\u00e4rztl Z"},{"issue":"5 Suppl","key":"10.1016\/j.tripleo.2011.01.017_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.joms.2009.01.009","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.01.017_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"5 Suppl","key":"10.1016\/j.tripleo.2011.01.017_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.joms.2008.12.007","article-title":"Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws","volume":"67","author":"Marx","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.01.017_bib34","first-page":"52","article-title":"Osteonekrose des Kiefers unter Bisphosphonat Langzeittherapie","volume":"8","author":"Gr\u00f6tz","year":"2005","journal-title":"Im Fokus Onkologie"},{"issue":"Suppl 2","key":"10.1016\/j.tripleo.2011.01.017_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1359\/jbmr.06s222","article-title":"Medical therapy in adults with fibrous dysplasia of bone","volume":"21","author":"Chapurlat","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.tripleo.2011.01.017_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.blo.0000201170.57141.66","article-title":"Osseointegration of cementless implants with different bisphosphonate regimens","volume":"447","author":"Eberhardt","year":"2006","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.tripleo.2011.01.017_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.rhu.0000208490.22492.09","article-title":"Alendronate treatment in osteogenesis imperfecta","volume":"12","author":"Madenci","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.tripleo.2011.01.017_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10006-008-0113-9","article-title":"Intralesional corticosteroid therapy for mandibular Langerhans cell histiocytosis preserving the intralesional tooth germ","volume":"12","author":"Moralis","year":"2008","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.01.017_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jpeds.2007.08.047","article-title":"Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis","volume":"152","author":"Simm","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.tripleo.2011.01.017_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2007.08.038","article-title":"Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: A case-control study","volume":"42","author":"Tse","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.01.017_bib41","series-title":"Bisphosphonate agents for the management of pain secondary to bone metastases: a systematic review of effectiveness and safety","author":"Wong","year":"2004"},{"key":"10.1016\/j.tripleo.2011.01.017_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tripleo.2006.09.021","article-title":"Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate","volume":"104","author":"Yamazaki","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210411000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210411000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T20:36:24Z","timestamp":1592426184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210411000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1079210411000217"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2011.01.017","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}